Related Experiment Video
Updated: Jun 15, 2026

05:57
Fat Preference: A Novel Model of Eating Behavior in Rats
Published on: June 27, 2014
Preference or fat? Revisiting opioid effects on food intake
1University of Utah School of Medicine, 420 Chipeta Way, Suite 1700, Salt Lake City, UT 84108, United States. s.taha@utah.edu
Physiology & Behavior
|March 10, 2010
Summary
Opioid signaling strongly influences food intake, particularly fat consumption. Individual food preferences may modulate this opioid effect on eating behaviors.
Area of Science:
- Neuroscience
- Behavioral Science
- Nutritional Science
Background:
- Opioid signaling in the central nervous system is a known potent stimulator of food intake.
- The specific role of opioids in determining food preferences remains less understood.
- Previous hypotheses suggest opioids promote intake of preferred foods or preferentially increase fat consumption.
Purpose of the Study:
- To comprehensively review existing studies on the role of opioids in food preference and intake.
- To elucidate the mechanism of opioid action in modulating food consumption, particularly fat intake.
- To differentiate the effects of endogenous versus exogenous opioid agonists on food preferences and macronutrient intake.
Main Methods:
- Review of published research investigating opioid signaling and ingestive behavior.
- Analysis of data to identify patterns in opioid-mediated food intake.
- Comparison of findings related to endogenous and exogenous opioid receptor agonists.
Main Results:
- Opioid effects on food intake appear largely specific to fat consumption.
- Individual animals' sensitivity to opioid-induced fat intake may depend on their baseline food preferences.
- Endogenous opioid effects might differ from exogenous agonists in altering baseline preferences versus macronutrient intake.
Conclusions:
- A unified mechanism suggests opioids primarily influence fat intake, with individual preferences modulating this effect.
- The selectivity of endogenous opioids may differ significantly from exogenous agonists in shaping food choices.
- Further research is needed to fully understand the nuanced role of opioid signaling in regulating appetite and dietary selection.
Related Concept Videos
Regulation of Food Intake
Short-term regulation of food intake primarily involves neural signals from the gastrointestinal (GI) tract, blood nutrient levels, and GI tract hormones. Communication between the gut and brain via vagal nerve fibers plays a significant role in evaluating the contents of the gut. Clinical studies have shown that protein ingestion produces a more prolonged response in these nerve fibers compared to an equivalent amount of glucose. Additionally, the activation of stretch receptors caused by GI...
Analgesia and Pain Management
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
Opioid Receptors: Overview
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2, D-Pen5]-enkephalin or DPDPE for...
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents
Diarrhea, a condition marked by frequent loose or watery bowel movements, can be triggered by multiple factors such as viral or bacterial infections, food intolerances, anxiety, medications, and digestive disorders. Symptoms may include abdominal pain, bloating, nausea, and cramping. Severe or prolonged diarrhea can lead to complications like electrolyte imbalances, malnutrition, and dehydration if left untreated.
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...

